Zoetis has announced the launch of Contacera (meloxicam) 15mg/ml oral suspension, a non-steriodal anti-inflammatory preparation for horses.
According to the company, meloxicam has been shown to hold advantages over Phenylbutazone for the alleviation of musculoskeletal inflammation and pain in horses over six weeks of age1,2,3,4.
Contacera can be mixed with food or syringed directly into the mouth to ensure compliance. It is available in 100ml or 250ml bottles, with a measuring dose syringe and a syringe adaptor. Contacera solution for injection is also available.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "Contacera is an exciting addition to our NSAID portfolio. Due to the potential clinical advantages of Meloxicam, Contacera gives vets an important additional option for NSAID management. It is a logical fit with the other products in our range and benefits from a choice of presentations."
For further information, contact your Zoetis Account Manager, visit www.zoetis.co.uk, or ring Zoetis' Customer Support: 0845 3008034
References
The RCVS has announced the launch of a consultation on the new proposed list of 'day-one' clinical skills needed by veterinary nurses when they first enter practice.
The College says it welcomes comments on the new list from veterinary nurses, veterinary surgeons and all those involved in veterinary nurse training and education.
The current Day-One Skills document was developed by RCVS Awards, the College's awarding body, in 2010 and provides a list of those skills student veterinary nurses are expected to have gained by the end of their training, and to be competent and confident in when they first go into practice.
As RCVS Awards will be closed by the end of this year, the RCVS is taking the opportunity to review the Day One Skills to bring them closer into line with our recently revised Day One Competences, and to reduce the number of required skills in order to make it more relevant to clinical practice.
Julie Dugmore, Head of Veterinary Nursing, said: "The current document was developed from an awarding body perspective and not that of the regulator, so it specifies a large number of non-clinical skills, for example, handling and moving equipment safely, which, while important, are somewhat out of our regulatory remit.
"Given the wide variety of veterinary practice settings to which student veterinary nurses are exposed, it is important that we, as the industry regulator, define the required day-one skills and ensure that these align with the required day-one competences. We need to review the skills list to ensure consistency, that it reflects current practice, and that it only includes those skills deemed necessary for registration purposes. A clearer focus on safe and effective clinical skills would support our primary regulatory role: that of protecting animal welfare and the public interest."
The consultation sets out the proposed Day-One Skills, grouped according to the corresponding day-one competences, and asks for feedback on their relevance, accuracy and completeness. Comments would be welcomed from higher education institutions, awarding organisations, centres, and training practices, as well as veterinary nurses and veterinary surgeons.
The consultation is available via the RCVS website at www.rcvs.org.uk/consultations and the deadline for responses is 5pm on 29 July 2015.
A group of some of the best-known referral practices in the country has issued a formal response to the recent announcement by pet insurance underwriter RSA that it is building a network of preferred referral practices to direct its clients to.
Whilst RSA has clarified the contents of a letter it sent to practices in the Midlands and North West, and apologised to the profession for the confusion it caused, it has not yet responded to any of the other concerns raised by the profession.
Perhaps chief amongst those is the claim by RSA's Head of Pet Claims, Keith Maxwell, that the company is looking to provide like-for-like treatment at a lower cost from its list of preferred referral practices.
Referral vets from Anderson Moores Veterinary Specialists in Hampshire, Cave Veterinary Specialists in Somerset, Davies Veterinary Specialists in Hertfordshire, Dick White Referrals in Suffolk, North Downs Specialist Referrals in Surrey, The Veterinary Cardiorespiratory Centre in Warwickshire and Willows Veterinary Centre in the West Midlands say that RSA's current list is simply not representative of the RCVS Recognised Specialist expertise and advanced therapies available within the veterinary profession, thereby making it impossible for RSA to offer like-for-like treatment, let alone at a lower cost.
Clive Elwood, Managing Director of Davies Veterinary Specialists in Hertfordshire, speaking on behalf of the practices who have expressed concern about the move, said: "An approach that focuses on cost-cutting rather than quality of patient care and lacks any genuine or objective process to benchmark clinical standards is inappropriate. Many multi-disciplinary centres place enormous value on the importance of Recognised Specialists being involved at every level of care including consultation, anaesthesia and imaging assessment and the proposed restrictions may preclude this level of service in some instances. We understand that balancing high standards of care and affordability for owners and insurance companies is an important issue and we hope insurers will work with all sectors of the profession to find constructive workable long term solutions."
Mike Martin of the Veterinary Cardiorespiratory Centre in Warwickshire added: "Owners buy pet insurance to ensure that they can access the best available expertise when their animals are ill. I don't think any owner wants to have their choice of practice restricted by insurance companies who are primarily concerned with encouraging shortcuts to reduce costs."
The British College of Veterinary Specialists has invited RSA to attend a meeting to discuss issues of concern, but says it hasn't thus far received a reply.
Gardner Llewlyn Veterinary Recruitment and VetSurgeon.org / VetNurse.co.uk have announced the winners of a competition in which people were invited to nominate nurses for a special thanks for the work they do.
67 entries from veterinary surgeons, veterinary nurses and pet owners made it onto the shortlist.
Jonathan Lewis from Gardner Llewlyn said: "I know it's a cliche, but it really was very hard to pick an outright winner. In the end, though, we just loved the sheer enthusiasm of Peter Howarth MRCVS's nomination for Louisa Bouchard RVN (pictured right) from the New Era Veterinary Hospital, and thought it takes a very special person to inspire the ringing endorsement of her work."
The team nomination was similarly difficult to pick. However, Stephanie Fursland MRCVS's nomination for the nursing team at The Oval Pet Centre stood out as an example of how a good nursing team can have a really profound effect on other members of the practice team.
A new iPad mini is on its way to Louisa, and a case of champagne is winging its way to The Oval Pet Centre. There was also a draw amongst all the nominators to win another iPad mini, the winner of which was Val Marsh, who nominated Kate Slack RVN from Blacks Veterinary Group.
Arlo Guthrie, Editor of VetSurgeon.org and VetNurse.co.uk said: "We found a lot of the entries really rather moving and whether they came from members of the public or from colleagues in the profession, they all serve to demonstrate the importance - as if anyone needed reminding - of what a good nurse brings to the practice. The nominees should all be very proud.
"We decided that the nominations were too good to keep to ourselves, so we've published them on a publicly visible part of VetNurse (click here), with links back to the nominated practices' websites. Hopefully, it might be a nice thing for any of the nominees to add to their CV, and the links should in time result in these lovely endorsements appearing when people make a relevant search for the practice."
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, is running an essay competition with a prize of an all-expenses-paid trip to the London Vet Show (London Olympia, 19th-20th November).
To win, you need to submit an essay of 1000 words or less which outlines an idea that will transform the veterinary/veterinary nursing profession by 2030. The College suggests that entrants might might look at a new business model, a new approach to education, a technological innovation or perhaps a way that the working lives of those in the practice team could be improved.
Anyone with an interest in the veterinary profession can enter the competition, including veterinary surgeons, nurses, practice managers and students.
The entries will be judged by the Vet Futures Project Board, which includes the Presidents and Chief Executives of both the Royal College of Veterinary Surgeons and the British Veterinary Association.
Entries will be anonymised then scored on a range of criteria, including originality, potential impact for the future and realistic prospects of change. The winning entry will be placed in a time capsule, to be opened by the veterinary profession in 2030.
The closing date for entries is midnight on Monday 31 August 2015, and the winner will be notified on Monday 7 September 2015.
The full rules and details of how entries can be submitted can be found on www.vetfutures.org.uk/essaycomp.
The Society for Practising Veterinary Surgeons (SPVS) has published its 2015 Fee Survey, which has revealed an increasing divergence between fees charged for routine and unroutine procedures in small animal practice.
SPVS says that small animal practices accounted for the largest proportion of responses to its survey, and that 75.9% of them had increased their fees during the last 12 months. When comparing a 'bundle' price comprising a kitten vaccination course, puppy vaccination course, cat spay, dog spay and consultation, the increase was 4.09%. However SPVS notes that this increase may be artificially low, as it relates to the sort of procedures that are regularly quoted and may therefore be constrained by the marketplace.
Perhaps more revealingly, whilst routine procedures such as vaccination had risen 3.3%, non routine procedures had risen by considerably more: pyometras were up 15.6%, cat dentals were up 17.5% and out-of-hours callouts were up 18.6%.
Equine fees showed an overall drop of 3.5% on the bundle price comprising initial routine examination, five-stage PPE, routine dental examination and float, a colic examination and the cost of sedation / waiting. Although many of the individual equine procedures showed a fee decrease, 79% of equine practices reported that they had increased fees over the past year. The largest decrease in equine fees was for sedating a horse and waiting while the horse was clipped or treated by an equine dental technician, with the fee charged being 12.5% less than last year and ranging from £12.50 to £93.82. Conversely, conducting an ultrasound scan of a mare for pregnancy had increased by 17.3% and ranged from £20 to £62.36.
For large animal vets, the fees are more tightly constrained by the commercial realities of farming and the range of fees quoted tends to be lower. This year, the overall price rise for the bundle of fees comprising routine calving, foot trimming, elective Caesarean and hourly rates for fertility work and herd health schemes was 4.1%. However, only 47.8% of large animal practices reported an increase in fees charged over the last twelve months. The largest increase reported was for paring the hind feet of a cow without sedation, which was up 24.4% and ranged in price from £19 to £70, while issuing a prescription to a farm animal client had decreased by 1.6% and ranged in price from 0 to £48.
Nick Stuart, SPVS president said: "We all know the industry is facing real challenges and this is reflected in the fee survey, with equine practices in particular decreasing many of their prices on last year. However the survey also shows that the fees vets charge vary widely, particularly in the small animal sector. While some of this can be accounted for by differing overheads, it does provide a fascinating insight into the various financial models that exist and challenges practice owners to review how they construct their fees. It also suggests that there is scope for practices to grow their profitability and understanding the market will help them with this.
"We have a new benchmarking service from Veterinary Insights that will help practices to set more accurate fee levels and we will be developing our fee survey further so that it dovetails with this service. I would urge practices to join SPVS and access the invaluable data we produce to help them grow their businesses."
For more information, a copy of the survey, or to join SPVS visit www.spvs.org.uk
Kruuse has announced that it has entered into an agreement with Henry Schein Inc., under which the American supplier of veterinary, dental and medical healthcare products and services will acquire a majority shareholding in the company.
Under the agreement - the financial details of which are not being disclosed - the Kruuse family will retain the remaining shareholding and work with Henry Schein to accelerate global expansion of the company.
Kruuse and Henry Schein have already been business partners in the marketing and distribution of animal healthcare products. Kruuse says it expects the deal to create significant growth prospects, particularly for its own products and brands which will in the future be included in Henry Schein's offering to its animal health customers.
Chairman of the Board of Kruuse, Peter Eriksen Jensen said: "We are very pleased with the agreement with Henry Schein, which fulfills our wish to find a strong investor to support our efforts of creating an attractive future for our company. We complement each other extremely well - and the partnership provides us with a much broader platform to market our products. In Henry Schein, we will get an ideal partner to realize our ambitious growth strategy."
Kruuse's CEO, Jesper Smith said: "It is very important to us, that we and our new owner have a mutual understanding of the values and customer-centric focus on quality and services which have guided us throughout Kruuse's 119 years' history. We will continue this approach under our new ownership, making sure that our employees, customers, and suppliers continue to experience all the benefits of Kruuse - now in an even stronger set-up and with new, exciting prospects for the future."
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has revealed the results of a survey which found that 59% of veterinary surgeons are optimistic about the future of the profession. 600 vets took part in the survey, which explored vets' attitudes towards their profession, and asked them to prioritise the key issues and rank some of the major threats and opportunities for the profession.Reducing stress was the single most important goal for the future, with 19% of respondents choosing it from a long list of options.The BVA and the RCVS say that priority goals for veterinary surgeons varied according to different areas of work and seniority in the profession. However, an overriding and uniting theme from the findings was the pursuit of recognition for the role vets play across the board. Vets' perception of the veterinary contribution to non-clinical roles, such as research, food supply and security, and public health, is high, but they don't believe the general public values these roles.Four of the respondents' top five goals for 2030 related to recognition:
Looking at how vets are respected and valued by society, Vet Futures points to its national ICM opinion poll of more than 2,000 members of the public which found that 94% of the general public trusts the veterinary profession generally or completely.
In terms of their own careers, 59% of vets said they felt that they had met or exceeded their expectations, leaving 41% saying their careers had only met some expectations (38%) or not met any (3%). Amongst this large minority of dissatisfied vets the reasons for their responses included: few opportunities for progression, pay, and working hours.The survey also asked vets to rank threats and opportunities for the profession and found that respondents considered the three greatest opportunities to be:
BVA President John Blackwell said: "It's heartening to see that, at the moment, the veterinary glass is half full for many. But we know that younger vets are disproportionately represented amongst those who are feeling less positive about their own careers, which is a real concern for future generations. There is clearly work to be done, through Vet Futures, for the profession to think innovatively in order to tackle some of their concerns around career progression, pay and working hours, as well as stress."The good news is that, through the Vet Futures UK-wide roadshow and our online engagement, we have been hearing new and interesting ideas for the future. We want to hear from as many vets, vet nurses and others who have a stake in the future of the profession and I would encourage people to get involved through our 'Veterinary Vision' essay competition or via the Vet Futures website."RCVS President Stuart Reid added: "There is a lot for the veterinary profession to be proud of but the Vet Futures survey shows that vets are concerned the general public doesn't understand or value the variety of roles we undertake outside clinical practice."We have also heard through our guest blog that vets working outside of practice sometimes feel that they are treated as second-class vets. "Through the Vet Futures project RCVS and BVA aim to address the lack of public awareness about the variety of roles undertaken by members of the profession, as well as increase understanding and access to these varied career opportunities amongst the profession. "We want to enable all veterinary surgeons to not only feel optimistic, but confident in their future."
Boehringer Ingelheim has launched Care and Connect a free online PPID aftercare service for horse owners, designed to help veterinary practices monitor their PPID case load and streamline the case management process.
The new service is part of Boehringer's 'Talk About Laminitis (TAL)' Awareness campaign.
The company says that PPID is the sixth most frequently encountered disease syndrome affecting equids in the UK1, and the new service should help engage owners and vets post diagnosis, thereby maximising treatment success.
Liz Barrett, equine business manager at Boehringer, said: “PPID is a progressive disease, so it is vital that veterinary surgeons remain at the centre of care, and that horses are monitored carefully following their initial diagnosis. However we recognise the high administrative demand associated with this, and TAL Care and Connect has been designed to reduce this as much as possible.”
TAL Care and Connect will be offered automatically to horse owners who take advantage of this year’s free* ACTH testing scheme, which will be available from July to November. Equine practices can also offer this aftercare service to all owners of previously diagnosed PPID cases.
Owners who join TAL Care and Connect will be able to set up a profile for their horse which allows all their ACTH results to be stored in one place. They will then receive the relevant reminders for follow-up ACTH testing which will make it easier for vets to monitor their patient’s progress over time.
In addition, owners can download an independently-written PPID information pack. Edited by Prof. Catherine McGowan with contributions from Dr Jo Ireland, Prof. Andy Durham, David Rendle and Dr Teresa Hollands, the pack includes advice on monitoring and follow-up ACTH tests, feeding, general care of the PPID patient and the link between laminitis and PPID.
Talk About Laminitis is supported by Redwings, The British Horse Society and World Horse Welfare, and will run from July until the end of October 2015. Horse owners can find out more and obtain their free ACTH voucher code at www.talkaboutlaminitis.co.uk.
For further information contact your local Boehringer territory manager or visit www.talkaboutlaminitis.co.uk.
*Cost of laboratory test
Virbac has launched Nutribound, a complementary feed to help stimulate eating and drinking in inappetent cats and dogs.
The company says the product has been designed to help animals recovering from surgery or illness and those that are just experiencing a general lack of interest in food or water.
Nutribound is given alongside the pet’s diet but can also be given by tube or syringe if needed.
Claire Lewis, Product Manager, said: "Pets that lose interest in their food can be challenging for owners to deal with - and a pet that is struggling to eat or drink what it needs, especially after illness or surgery is more likely to have a prolonged recovery.
"Nutribound's palatable formulation aims to 'jump-start' normal eating behaviour by stimulating the animal's appetite and increasing its interest in eating and drinking again.
"Nutribound is presented in a handy-sized, take-home bottle and is easy for pet owners to administer. It can be given for up to 14 days or until a return to normal eating and drinking behaviour is observed. We are delighted to add it to our nutritional support range, alongside Nutri-Plus gel, our high energy, nutritional supplement for cats and dogs."
The London Vet Show has announced it will be offering delegates the chance to win a £12,000 trip to Thailand with Worldwide Veterinary Service (WVS) at this year’s event (Olympia Grand, 19th & 20th November).
Delegates will be able to enter the competition by collecting a stamp in their LVS passport from each of the participating sponsors’ stands in the exhibition.
The 13-day working holiday kicks off by flying to Chang Mai in Thailand via Bangkok. The winners will then travel to the Narittaya Resort and Spa where they'll be staying in a private villa with its own pool. Working over the next six days with the WVS team in Chang Mai, they will be supporting an ongoing neutering and vaccination campaign while also training local vets in best practice surgical techniques.
The winners will get the opportunity to explore the temples in the ancient city of Chang Mai and a highlight of the trip will be an overnight visit to the Elephant Nature Park, which is dedicated to providing care and assistance to Thailand’s captive elephant population. The overnight stay will include a full orientation of the park and the elephants and a chance to bathe and swim with the herd in the river and communicate with them.
The winners will also have a chance to go either white water rafting or bamboo rafting.
For further information on the London Vet Show or to register to attend the event visit londonvetshow.co.uk.
CVS has announced that it is to support the Small Animal Veterinary Surveillance Network (SAVSNET), a charity initiative run jointly by the BSAVA and the University of Liverpool to monitor health and illness in companion animals using anonymised data from veterinary practices and laboratories.
The group will be linking its practices, of which there are now more than 290, to SAVSNET through their practice management systems in a rollout that will continue until the end of the year.
Through its research and analysis, SAVSNET aims to monitor disease trends over time; identify populations at risk and monitor treatments and outcomes. It also aims to provide data and improve public awareness of small animal diseases and prevention. One of its projects delivers near-real-time (within 24 hours) practice-based syndromic surveillance based on data received from participating veterinary surgeons, who through a single mouse click, record information at the end of each consultation through their practice management system. The data is automatically sent to SAVSNET for secure storage and analysis. The whole process is designed to avoid any impact on a practices already busy work flow.
Dr Alan Radford, one of SAVSNET’s principal investigators, said: "Reusing electronic health data has a massive potential to improve animal and human health. SAVSNET is one project leading the way in this research and it is great to be working with CVS, with its scale and also its focus on high quality veterinary care.
"Working together, SAVSNET and members of the CVS team can really help understand in a new way the diseases seen by the populations under our care. As a small thank you for participation, practices that take part are provided with a secure on-line portal where they can see free anonymised benchmarking statistics including disease data and antibacterial use. Greater knowledge will enable us to target interventions to those animals most at risk, to identify risk factors for disease and to focus veterinary research efforts."
Marcus Evans, Head of Practice Management Systems at CVS said: "We are very impressed at the projects being carried out by the SAVSNET team and are keen to support its work, particularly as our veterinary teams can do it so quickly and easily through RoboVet, our practice management system. As a large veterinary group, and one that is continuing to grow rapidly, our support will add significant weight to SAVNET's efforts and we are delighted to be contributing to such valuable research."
Researchers at the Animal Health Trust are appealing for information from veterinary surgeons who have seen recent Eosinophilic Keratitis (EK) conditions, an emerging issue in UK equine ophthalmology.
The AHT says that despite the increased awareness of EK worldwide, the aetiopathogenesis of the disease remains poorly understood and probably underdiagnosed. The charity is looking to define the pathogenesis and determine why some horses are particularly susceptible to this condition, in particular looking for epidemiological links, environmental factors and parasitic infestation.
Many of the clinical signs of EK are non-specific and similar to other corneal conditions such as blepharospasm, chemosis, conjunctival hyperaemia, epiphora or perilesional oedema. More specific signs include caseous mucoid discharge and white/yellow plaques often localised in the peripheral cornea. The degree of pain varies and concurrent ulceration is almost always present. Conjunctivitis may also occur in association with the keratitis or as a unique disease entity.
EK can have variable clinical presentations, from a thick caseous accumulation to a more superficial plaque of “ground-glass” appearance. They may present as chronic non-healing ulcers that respond quickly to the use of topical steroids and/or ciclosporin, or present with marked ocular discomfort and require superficial keratectomy to resolve the condition.
Two different corneal locations are classically (though not exclusively) involved in EK, the medial perilimbal cornea, often under the third eyelid, or the lateral perilimbal cornea, which may progress axially towards the central cornea.
The charity is also providing free cytology tests for corneal scrapes to help vets diagnose EK earlier, thereby avoiding secondary complications that can lead to permanent visionary impairment.
If you have seen cases that have either been diagnosed as or that you suspect to be Eosinophilic Keratitis this year, contact Sonia Gonzalez-Medina on 01638 751000 Ext: 1203 or sonia.gonzalez-medina@aht.org.uk.
For more information and to download a copy of the submission form to accompany samples, visit www.aht.org.uk/EKstudy.
The RCVS has published a new video which explains the Professional Development Phase (PDP) and highlights the support it provides for new veterinary graduates as they develop their Year One Competences.
In the video, Victoria Henry MRCVS - who works at Mandeville Veterinary Hospital in Northolt - speaks about how the PDP has helped her move from being a newly-qualified graduate to becoming a confident practitioner. She said: “It’s a massive transition coming out of vet school and going into practice – you suddenly have all the responsibility and it’s all on you. The PDP gives you goalposts to work towards and flags up the areas you don’t have much practice in; it helps you to reflect on what you’ve been doing and assess yourself.”
Jeremy Stewart, the Head Veterinary Surgeon at Mandeville Veterinary Hospital, talks about how the PDP helps employers to support and develop graduates like Victoria by building their confidence and helping them gain the experience they need for practice life.
The video also highlights the support available for graduates undertaking the PDP and features Julian Wells, one of the five Postgraduate Deans who help graduates undertaking the PDP by providing advice on any issues they may encounter, checking their progress and confirming when they have completed it. He also describes how the PDP helps graduates to understand the mentoring role in practice, which they can then provide to new graduates as they progress through their own careers.
Christine Warman, Head of Education at the RCVS, said: “With 859 new UK graduates having just joined the Register, we thought this video would be helpful in setting out why the PDP can be so crucial in helping to build the confidence and experience of new graduates, as well as the fact that it can easily be incorporated into day-to-day work.”
More information about the PDP is available by visiting www.rcvs.org.uk/pdp or by emailing pdp@rcvs.org.uk.
Veterinary surgeons who wish to sign up to the Professional Development Record can do so by visiting www.rcvs-pdr.org.uk
Virbac has launched Neoprinil, an eprinomectin pour-on solution indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles.
Neoprinil has a zero-day withdrawal period in milk and can be administered using the company's Farmpack and Flexibag.
The Farmpack is a backpack which holds a Flexibag of Neoprinil solution. The Flexibag is a bag designed to protect medication and preserve it once it has been opened. The two together were awarded the 2014 PharmaPack Award for Innovative Packaging.
Neoprinil offers a one year stability period once it has first been opened and requires no special conditions for storage. It is presented in 2.5L, 4.5l and 8l pack sizes.
Product Manager for Large Animals Brigitte Goasduf MRCVS said: "A high worm burden can have adverse effects on the herd's productivity and performance and so it is advisable to ensure infected animals are treated as part of a Herd Health Plan. Eprinomectin is a tried and trusted parasiticide and studies confirm that it can have a positive impact on both milk production and on weight gain. Its zero day withdrawal period is a major benefit for dairy farmers.
"With the launch first of Deltanil and, now, Neoprinil, we are reinforcing our commitment to work with veterinary surgeons and farmers to understand the everyday challenges they face and to provide practical, effective solutions. We offer a comprehensive parasiticide range with a dispensing system that sets a new standard for convenience and ease of use."
Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.
According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure because it helps reduce pulmonary oedema and its quick onset of action is associated with a noticeable reduction in clinical signs.
However, Ceva highlights the fact that long-term under or over-dosing can have profound health implications for the patient, and says that current recommendations are to reduce the dose to the minimum effective dose as soon as the animal is stable and only increase it if required due to deterioration in heart function.
Ceva says that unlike other furosemides, Libeo has been designed solely for the veterinary market - specifically to facilitate easy and accurate dosing.
The four-way break tablet is available in a traditional 40mg tablet size as well as a unique 10mg size for small patients. The clover-shaped tablet is chicken-flavoured, designed to make it easier for owners to dose their pets and help improve long-term owner compliance. Each box of Libeo contains 120 blister-packed tablets, removing the need for someone to have to count out tablets.
Rob McLintock MRCVS, Companion Animal Business Unit Manager at Ceva Animal Health said: “87% of vets in the UK believe that the dose of furosemide given to pets by their owners is adversely affected by how difficult it is to split the tablets1. This is especially likely to affect pets whose owners are less dextrous or have difficulties using their hands. Libeo is both easy to administer and effective, thereby improving owner compliance and the long term health and welfare of their pets.”
Reference
Lincolnshire veterinary surgeon David Bull MRCVS has won a Vet Futures ‘Headlines of tomorrow’ competition with his entry: ‘Vets and medics collaborate to prevent human and animal obesity’.
The competition was held at BSAVA Congress in April where Vet Futures-themed fortune cookies contained a message asking those attending ‘What future headline do you want to see?’ and providing a weblink to enter the competition.
David, a joint partner at Vets4Pets in Lincoln South and an Advanced Practitioner in General Small Animal Surgery, said: "The headline was inspired by topical issues, having ‘One Health’ in mind and the issue of obesity in our patients, as well as the general human population. I feel that these are some of the big issues of our time, especially that of obesity which has been linked to so many other diseases and is essentially a self-induced problem.
“We see so many overweight cats, dogs and rabbits on a daily basis. It seems to be becoming a more common problem, as well as seemingly more accepted in society. This is to the extent that we have some clients that come in worried because they have been told that their dog is too thin, when in actual fact they are in an ideal body condition and are being compared to overweight pets which have become perceived as normal.”
Some of the other topics raised in the competition include the veterinary profession taking the lead in tackling ‘superbugs’, veterinary surgeons topping job satisfaction and wellbeing polls and the profession taking a leading role in One Health and medical advancements.
Scientists from the Animal Health Trust, the Wellcome Trust Sanger Institute and the University of St. Andrews have pinpointed the genes which allow the bacteria responsible for strangles to thrive, thereby paving the way for the development of a vaccine.
In the study, which the researchers say was the largest of its kind, 224 samples of Streptococcus equi (S. equi) were procured from horses around the globe to try and find a common bacterial ancestor from which modern strains would have developed. Despite the disease first being described in 1251, the researchers were surprised at the genetic similarity of the samples and identified a total population replacement at the 19th or early 20th century. This corresponds to a period when horses from around the world were brought together in global conflicts including World War I, where an estimated eight million horses died on the battlefield.
Dr Simon Harris from the Wellcome Trust Sanger Institute said: “The mobilisation and mixing of horses in conflicts such as WWI provided perfect conditions for S. equi to thrive. This combined with high mortality rates among the horses and their replacement with young susceptible horses could explain what we see around the world today".
While loss of diversity could be considered detrimental to bacterial populations, S. equi still infects more than 20,000 horses in the UK alone each year. Its success, researchers believe, is due to its ability to persist in some horses for years after they have recovered from strangles, where the bug can evolve to evade the horse’s immune system.
Dr Andrew Waller, Head of Bacteriology at the Animal Health Trust said: “The data we have gathered in this study has enabled us to pinpoint the genes that help the bacteria to persist, spread and thrive in the horse population. This research provides an unprecedented opportunity to reduce the impact of and prevent strangles in future generations of horses.”
The AHT says that the ability of S. equi to adapt to living in a persistent state within its host and still infect new horses mirrors the situation with HIV and the bacteria that causes tuberculosis in humans. Dr Matthew Holden from the Wellcome Trust Sanger Institute and the University of St Andrews said: “Unravelling the complex population dynamics of S. equi sheds new light on the balancing act between acute and persistent infection that is going on in many pathogens. Not only does this collection of whole-genome sequences for S. equi offer hope for an effective strangles vaccine, it also provides us with a useful model for understanding persistent infection in humans.”
Bayer Animal Health has announced changes to the product indications for Baytril 50mg/ml and 100mg/ml Solutions for Injection, which both contain enrofloxacin.
Baytril 50mg/ml and 100mg/ml Solutions for Injection, now have licensed indications for the treatment of sheep and goats.
Baytril 50mg/ml and 100mg/ml* Solutions for Injection are now licensed for the treatment of acute mycoplasma-associated arthritis due to enrofloxacin- susceptible strains of Mycoplasma bovis in cattle (*in cattle less than 2 years old.)
For the treatment of acute severe mastitis caused by enrofloxacin - susceptible strains ofEscherichia coli in cattle, the second injection of Baytril 100 mg/ml Solution for Injection may now be given subcutaneously, 24 hours after the first dose administered by intravenous injection. In this case, the withdrawal period following subcutaneous injection should be applied.
For more information, refer to the product data sheets at www.noahcompendium.co.uk and SPCs or speak to your local Bayer Animal Health representative.
The RCVS reports that its alternative dispute resolution (ADR) trial is now nearing completion with over two-thirds of its target number of cases either resolved or in process.
The year-long trial, which began in November 2014, aims to gather the evidence needed to develop a permanent scheme which would provide a way of adjudicating on concerns raised about a veterinary surgeon that do not meet the RCVS threshold of serious professional misconduct.
The aim of the trial, which is administered by the independent, not-for-profit Ombudsman Services, is to make determinations on around 100 cases in order to gather information about types of concern, time taken to resolve disputes, recommendations and how likely each party is to accept recommendations. As of this week some 72 cases have been referred to the trial scheme, with final decisions made in relation to 54 of these cases.
RCVS CEO Nick Stace was responsible for pushing forward the trial believing that “what is good for the consumer is good for the profession”. The College also says it brings it into line with a European Union Directive on alternative dispute resolution which, while not legally binding, specifies that regulators and other ‘competent authorities’ should have consumer redress systems in place.
Nick said: “The majority of cases are either being determined in the veterinary surgeon’s favour or finding that they need take no further action in order to resolve the dispute. Where recommendations have been made in favour of the client, the suggested remedies have generally been for a small goodwill payment to be made.
“However, the trial has not been without some frustrations so far. The fact that participation in the trial is entirely voluntary has meant that, in many cases, members of the profession have chosen not to take part.
“With this in mind, it is very important to stress the benefits of the trial to the profession – chiefly that many of the vets who chose to take part have had their actions exonerated by Ombudsman Services in a way that a concern being closed by our Professional Conduct Department does not. For clients, where a vet does have a case to answer, it gives them the chance to seek recompense without having to resort to legal action.
“Regardless of which way the decision goes in any of these cases, participating in the trial can bring these often long-standing and burdensome disputes to a close.”
The trial will continue to run until the end of October and a full report and recommendations will be presented to RCVS Council at its meeting on Thursday 5 November 2015. Full details of the trial and its parameters can be found at www.rcvs.org.uk/adr
Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.
The Atopica Comfort Club loyalty scheme now has a new website which enables all members of the practice team to see the cases being managed and the offers available for new and existing users post diagnosis. The initiative provides veterinary practices with a free of charge Atopica redemption scheme through both induction and maintenance periods.
Elanco says the new website will also enable veterinary practices to view and redeem offers instantly, receive reminders about offers and updates together with emails to confirm offers have been redeemed and the products despatched.
Alice Laurens, DVM MRCVS, Dermatology Marketing Manager at Elanco Animal Health, said: “The Comfort Club loyalty scheme embraces a multi-modal approach and ensures better comfort is provided to Atopica patients with options to offer a flea product, shampoo, essential fatty acids and an adapted diet.”
To support the new Atopica Comfort Club loyalty program, Elanco has also produced a ‘practice log book’ to enable vets to record details on each case which can then be entered onto the Comfort Club website.
For further information, or to book a lunch and learn meeting, please contact your local Elanco Animal Health key account manager or email elancoCAH.uk@elanco.com.
CVS has announced its acquisition of the Dovecote Veterinary Hospital, a general and referral practice based in Castle Donington near Derby.
The Dovecote offers a range of referral services including digital X-ray, MRI and CT scanning capability. Its directors, Andrew Robinson, a European RCVS Recognised Specialist in Small Animal Surgery, and Alison Robinson have been appointed joint Clinical Directors.
Dovecote joins ChesterGates Veterinary Specialists in Chester, Norfolk-based Grove Referrals and St David's Veterinary Group in Devon in CVS' referral practice portfolio. The Group also has a new veterinary hospital - Lumbry Park Veterinary Specialists - under construction at Alton, Hampshire; opening in October 2015.
In addition to the Dovecote, CVS has announced the acquisition of further first opinion practices based in Yorkshire and Wales. They are:
Simon Innes, Chief Executive of CVS, said: "These latest acquisitions show continued progress towards our goal of building a strong presence throughout all sectors of veterinary practice. It is a particularly exciting time for our referral team and we are delighted to welcome the team from Dovecote, as well as the other new practices which have joined us recently."
The RCVS Disciplinary Committee has agreed to accept undertakings from a Dorset veterinary surgeon, Philippa Ann Rodale MBE, in which she requests that her name is removed from the RCVS Register of Veterinary Surgeons with effect from 31 July 2015, and undertakes never to apply to be restored to it.
The Committee met on Monday 17 August, resuming a hearing which had been adjourned on 20 July. The adjournment had been made to allow Ms Rodale time to submit formal responses to the charges against her and indicate whether she agreed with them. In the event, as outlined by a letter from her solicitors received by the College on 14 August, Ms Rodale declined to comment on the charges and did not admit to any of them.
Ms Rodale did not attend the hearing on 17 August, however, the Committee decided to continue in her absence, on the understanding that, as evidenced by her solicitors’ letter, she was fully aware of the hearing and had voluntarily waived her right to be presented and represented.
The original charges related to Ms Rodale’s standards of practice (in relation to issues such as biosecurity, hygiene, in-patient facilities, drug storage and the disposal of hazardous waste, among other things) and also to a test for Intradermal Comparative Tuberculin. The charges relating to her standards of practice did not have complainants, as the College raised the matters itself; with respect to the Tuberculin test charge, the Animal and Plant Health Agency, as the relevant body, raised no objection to the proposed course of accepting undertakings.
In accepting the undertakings, the Committee felt that a contested hearing that could take up to seven days and involve up to eight witnesses for the College and up to three for the Respondent would not be in the public interest. Furthermore, since the 20 July hearing, Ms Rodale had retired and closed her practice. The Committee also noted that there had been no previous disciplinary findings against her, in what was otherwise a long and unblemished career.
Ian Green, chairing the Committee and speaking on its behalf, said: “The Committee is satisfied that the undertakings offered by the Respondent protect the welfare of animals since the Respondent has now retired and is no longer in practice. It is also satisfied that the reputation of the profession is upheld since the undertakings offered go beyond any sanction which the Committee could impose at the conclusion of a contested hearing, were any of the Heads of Charge to be found proved. It considers that it would not be proportionate or in the public interest for there to be a lengthy contested hearing.”
Zoetis has announced the launch of Zulvac SBV, a new Schmallenberg vaccine licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Zulvac SBV is licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Duration of immunity is six months in cattle and seven in sheep. At the recommended vaccination timing, this covers the window of susceptibility during pregnancy; in sheep from day 28 to 56, and days 70 to 150 in cattle. Animals infected during these periods are at risk of malformed offspring and subsequent stillbirth.
The company says vaccination combined with insecticidal measures to control the midge vector remains the most effective way of protecting the population1 and ensuring a more unified level of immunity.
Zoetis vet Carolyn Hogan said: "Although SBV is now considered to be an enzootic pathogen in England and Wales, there is plenty of evidence that seroprevalence at farm level – particularly on sheep farms - varies. As immunity wanes, the proportion of herds and flocks naïve to SBV and at risk via introduction of naïve replacements increases. So the risk of reinfection in assumed enzootic areas is potentially underestimated2.
"Culicoides midges, the SBV vector, are widespread in Europe and move easily between farms and regions, allowing rapid spread of infection."
Carolyn says that whilst there have been no confirmed diagnoses of congenital abnormalities in calves or lambs from APHA in 2014 or 2015, unconfirmed anecdotal cases have been reported.
"We do not know whether our ruminant population is immune or susceptible and neither do we know if another SBV challenge will appear. Vaccination remains the most effective way of ensuring valuable livestock are protected."
Supplies are available immediately.